• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA VITEK® MS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA VITEK® MS Back to Search Results
Model Number 410895
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Manufacturer Narrative
Device not returned to manufacturer.
 
Event Description
A customer in (b)(6) contacted biomérieux to report a misidentification of micrococcus luteus/lylae as arcanobacterium haemolyticum in association with the vitek® ms system.The customer stated there was no impact on patient reporting; there was a minor delay since they had to repeat testing.In addition, the customer reported the occurrence of a group c streptococcus misidentified as streptococcus pyogenes.Reports were not sent out to the physician.Customer repeated testing and performed agglutination tests for confirmation; confirmatory testing via agglutination returned a result of group g streptococcus.The log files from the vitek® ms were submitted for evaluation.The results indicated that fine-tuning, spot preparation, and/or culture conditions may have caused the misidentification.When the misidentification occurred, "all peaks" criteria and "good peaks" criteria were below the threshold.The local field service engineer visited the customer site and performed a fine-tuning procedure.Subsequent specimen testing by the customer indicates the issue now seems to be resolved.There is no indication or report from the laboratory or physician that the discrepant result led to any adverse event related to any patient's state of health.Culture submittal was requested by biomérieux for internal investigation.Biomérieux investigation has been initiated.
 
Manufacturer Narrative
This report was initially submitted following notification that a customer in canada experienced a misidentification of micrococcus luteus/lylae as arcanobacterium haemolyticum in association with the vitek® ms system.Internal biomérieux investigation was performed.The investigation concluded that the issue occurred as a result of poor/inconsistent spot preparation.The data log analysis indicates the initial tests performed by the customer show only 25 and 33 peaks are present, while the repeat spots show 53 and 55 peaks present, respectively.Lower peak counts can lead to organism misidentification.As a precaution, instrument fine-tuning was performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITEK® MS
Type of Device
VITEK® MS
Manufacturer (Section D)
BIOMERIEUX SA
chemin de l orme
marcy l etoile, rhone 69280
FR  69280
Manufacturer (Section G)
BIOMERIEUX, INC
595 anglum road
st. louis MO 63042
Manufacturer Contact
ellen weltmer
595 anglum road
hazelwood, MO 63042
3147317301
MDR Report Key6063510
MDR Text Key59016108
Report Number3002769706-2016-00455
Device Sequence Number1
Product Code PEX
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
K124067
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 02/27/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/28/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number410895
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/31/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-